| HRs | hormone receptors |
| ER | estrogen receptor |
| PR | progesterone receptor |
| HER2 | human epidermal growth factor 2 |
| RT | radiotherapy |
| LB | liquid biopsies |
| CTCs | circulating tumor cells |
| ctDNA | cell-free circulating tumor DNA |
| EpCAM | epithelial cell adhesion molecule |
| EVs | extracellular vesicles |
| cfDNA | cell-free DNA |
| RT-qPCR | real-time quantitative PCR |
| WGS | whole-genome sequencing |
| WES | whole-exome sequencing |
| MAFs | mutant allele frequencies |
| ddPCR | digital droplet PCR |
| Erα | estrogen receptor alpha |
| AIs | aromatase inhibitors |
| NGS | next-generation sequencing |
| SNPs | single nucleotide polymorphisms |
| TARDIS | targeted digital sequencing |
| MVBs | multivesicular bodies |
| IDC | invasive ductal carcinoma |
| DCIS | ductal carcinoma in situ |
| TME | tumor microenvironment |
| miRNAs | microRNAs |
| GSTP1 | glutathione S-transferase P1 |
| TK1 | thymidine kinase 1 |
| CDK9 | cyclin-dependent kinase 9 |
| Hsps | heat shock proteins |
| Del-1 | developmental endothelial locus-1 |
| UCH-L1 | ubiquitin carboxyl-terminal hydrolase-L1 |
| P-gp | P-glycoprotein |
| TrpC5 | transient receptor potential channel 5 |
| EMT | epithelial-mesenchymal transition |
| MBC | metastatic breast cancer |